怎样找一个靠谱的网投

X

Accord Healthcare

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to over 70 markets around the world.
 

REPORT A SIDE EFFECT

report

Falsified Medicines Directive

GROWTH’S IN OUR NATURE

With an extensive presence in all regions of the world, Accord Healthcare has very rapidly become one of the fastest growing generic pharmaceutical companies.

Our robust product portfolio in growth-oriented therapies allows us to compete with some of the biggest portfolios in the industry, as well as helping to extend our presence into new markets.

怎样找一个靠谱的网投Accord’s operations began with a strategic vision to create a global brand, supported by a commercial infrastructure that enables us to bring our high quality yet affordable products to patients around the world. We commit ourselves to challenging the unmet medical, societal and patient needs of the day.

01

TRULY MULTINATIONAL

Accord Healthcare is the international arm of Intas Pharmaceuticals Ltd., with commercial operations in more than 70 countries globally and close to 65 EMENA markets. The first Accord commercial operations in Europe were recorded in 2008 in the United Kingdom. Currently, our portfolio comprises 423 generic INNs, including 50 novel Added Value Products.

02

A COMPLETE APPROACH

Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.

04

News

28-04-2020

Accord Healthcare ready to fill UK COVID drug shortages

Accord Healthcare announces a significant change to the way 怎样找一个靠谱的网投the UK receives hydroxychloroquine (HCQ), a medicine under investigation during COVID-19. 

17-04-2020

Accord Healthcare addresses shortages of critical ventilator medicines for COVID-19 patients

The Department of Health and Social Care (DHSC) announced yesterday, 16 April 2020  that the UK’s supplies of the vital muscle relaxant medicines (atracurium and cisatracurium) used in patients on mechanical ventilators will be exhausted in the next few days via the MHRA.

手机棋牌输了几百万 快钱彩票官网 怎么购买手机赌博软件 我爱彩票邀请码是多少 怎么样进入赌单双软件 快乐棋牌游戏 手机版彩票过滤工具 怎么下载波克棋牌 我想查查彩票开奖结果 怎么举报网络彩票